|
全球冠状病毒疫苗专利分析
Patent Analysis of Global Coronavirus Vaccine
查看参考文献10篇
文摘
|
冠状病毒是一类可感染人类和动物的RNA病毒,可引起严重急性呼吸综合征( SARS)和中东呼吸综合征( MERS)等严重疾病。新型冠状病毒是以前从未在人体中发现的冠状病毒新毒株,其人际传播迅速,引起了各国政府的高度重视并积极寻求疫苗防控对策。基于冠状病毒疫苗领域全景专利,在综合对比分析该领域的全部专利的发展趋势、主要国家和主要机构的专利产出的同时,重点揭示了其中的人用相关疫苗的发展与分布情况以及重点分析了人用疫苗产品的研发现状,以期为我国冠状病毒疫苗领域的科研工作者和管理决策者提供参考数据。 |
其他语种文摘
|
Coronavirus is a kind of RNA virus which can infect human and animals. Coronavirus can cause severe diseases such as Severe Acute Respiratory Syndrome ( SARS) and Middle East Respiratory Syndrome ( MERS). The coronavirus ( SARS-CoV-2) is a new strain which has never been found in human body before. The rapid transmission of SARS-CoV-2 has aroused the attention of governments all over the world and actively sought for vaccines. This report based on the panoramic patent in the field of coronavirus vaccine, comprehensively analyzed the development trend of patents,the output of major countries and institutions. At the same time,the report focuses on revealing the development and distribution of human related vaccines,as well as the research and development status of human related vaccine products. The report aims to provide references and implications for scientific researchers and decision makers in the field of Coronavirus Vaccine. |
来源
|
中国生物工程杂志
,2020,40(1/2):57-64 【核心库】
|
DOI
|
10.13523/j.cb.2002105
|
关键词
|
冠状病毒
;
SARS-CoV-2
;
COVID-19
;
疫苗
;
人用疫苗
;
专利分析
|
地址
|
中国科学院文献情报中心, 北京, 100190
|
语种
|
中文 |
文献类型
|
研究性论文 |
ISSN
|
1671-8135 |
学科
|
生物工程学(生物技术) |
文献收藏号
|
CSCD:6774317
|
参考文献 共
10
共1页
|
1.
Gorbalenya A E. Nidovirales: evolving the largest RNA virus genome.
Virus Res,2006,117:17-37
|
被引
31
次
|
|
|
|
2.
.
Science Daily. Study: Pig virus is easily transmitted among chickens and turkeys,2020
|
被引
1
次
|
|
|
|
3.
CEPI. CEPI to fund three programmes to develop vaccines against the novel coronavirus.
nCoV-2019,2020
|
被引
1
次
|
|
|
|
4.
CNBC.
Moderna working with the NIH on coronavirus vaccine,2020
|
被引
1
次
|
|
|
|
5.
.
GSK. CEPI and GSK announce collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus,2020
|
被引
1
次
|
|
|
|
6.
Song Z. Pub crosstef From SARS to MERS, thrusting coronaviruses into the spotlight.
Viruses,2019,11(1):E59
|
被引
5
次
|
|
|
|
7.
Zhang N. Receptorbinding domain-based subunit vaccines against MERS-CoV.
Virus Res,2015,202:151
|
被引
7
次
|
|
|
|
8.
Schindewolf C. Middle East respiratory syndrome vaccine candidates: Cautious optimism.
Viruses,2019,11(1):E74
|
被引
3
次
|
|
|
|
9.
Cho H. Development of Middle East respiratory syndrome coronavirus vaccines-Advances and challenges.
Hum Vaccin Immunother,2018,14(2):304
|
被引
2
次
|
|
|
|
10.
Li F. MERS coronavirus: An emerging zoonotic virus.
Viruses,2019,11(7):E663
|
被引
2
次
|
|
|
|
|
|